Literature DB >> 1285501

The inhibition of lymphocyte blastogenesis by asparaginase: critical role of glutamine in both T and B lymphocyte transformation.

T Kitoh1, S Asai, Y Akiyama, M Kubota, H Mikawa.   

Abstract

L-Asparaginase has long been used in the treatment of acute lymphoblastic leukemia or malignant lymphoma in childhood. To determine cell type specific sensitivity to this drug, the L-asparaginase-mediated inhibition of blastogenesis of human peripheral T or B lymphocytes was compared. The rate of incorporation of [3H]-thymidine into the DNA of either T lymphocytes due to phytohemagglutinin (PHA) or B lymphocytes due to Staphylococcus aureus Cowan I (SAC) was measured by the addition of Escherichia coli L-asparaginase in the medium. The blastogenic response of either T or B lymphocytes was also determined in medium depleted of exogenous asparagine and/or glutamine, both of which are hydrolyzed by this enzyme. The in vitro blastogenesis of either human T lymphocytes due to PHA or B lymphocytes due to SAC was inhibited by the inclusion of asparaginase in the medium. The deprivation of exogenous asparagine did not have any inhibitory effect on the blastogenic response of both T and B lymphocytes to each mitogen. On the other hand, the glutamine concentration in the culture medium provided a critical influence on the proliferative response of T and B lymphocytes. The rate of incorporation of [3H]-thymidine into DNA was increased markedly as the concentration of glutamine was increased from 2(-7)-2 mmol/l. It is concluded that the mechanism of inhibition of PHA- or SAC-stimulated lymphocyte blastogenesis by L-asparaginase is not asparagine deprivation but glutamine deprivation. Glutamine, which is the most abundant amino acid, is thought to have an important role in the immune response of lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1285501     DOI: 10.1111/j.1442-200x.1992.tb01012.x

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN: 0374-5600


  5 in total

1.  The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.

Authors:  Wai Kin Chan; Philip L Lorenzi; Andriy Anishkin; Preeti Purwaha; David M Rogers; Sergei Sukharev; Susan B Rempe; John N Weinstein
Journal:  Blood       Date:  2014-03-21       Impact factor: 22.113

2.  The eIF2 kinase GCN2 is essential for the murine immune system to adapt to amino acid deprivation by asparaginase.

Authors:  Piyawan Bunpo; Judy K Cundiff; Rachel B Reinert; Ronald C Wek; Carla J Aldrich; Tracy G Anthony
Journal:  J Nutr       Date:  2010-09-22       Impact factor: 4.798

Review 3.  Metabolic reprogramming and metabolic dependency in T cells.

Authors:  Ruoning Wang; Douglas R Green
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

Review 4.  Asparagine synthetase: a new potential biomarker in ovarian cancer.

Authors:  Philip L Lorenzi; John N Weinstein
Journal:  Drug News Perspect       Date:  2009 Jan-Feb

5.  Targeted metabolomic analysis of amino acid response to L-asparaginase in adherent cells.

Authors:  Preeti Purwaha; Philip L Lorenzi; Leslie P Silva; David H Hawke; John N Weinstein
Journal:  Metabolomics       Date:  2014-02-07       Impact factor: 4.290

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.